Patents/Assignees

Novartis Pharmaceuticals Corporation

1 patent in portfolio

US11642329utility2023
Amorphous Solid Form of Compounds Containing S—n-valeryl-n- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic Acid Ethyl Ester Moieties and Sodium Cations
0 cites